Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates - Wikidata - awgldk - TriplyDB

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

http://www.wikidata.org/entity/Q33993597

about

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View FSGS: Diagnosis and Diagnostic Work-Up A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues suPAR and Team Nephrology Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infection Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models.Novel biomarkers in glomerular disease.Immunopathogenesis of idiopathic nephrotic syndrome with relapse.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.Causes and pathogenesis of focal segmental glomerulosclerosis.Recurrent focal segmental glomerulosclerosis after kidney transplantation.Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.Focal segmental glomerular sclerosis: do not overlook the role of immune response.Novel Biomarkers for Renal Diseases? None for the Moment (but One).Optimal management of primary focal segmental glomerulosclerosis in adults Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome.Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?Is there clinical value in measuring suPAR levels in FSGS?A case report of adrenocorticotropic hormone to treat recurrent focal segmental glomerular sclerosis post-transplantation and biomarker monitoring.Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.Precision Transplant Medicine: Biomarkers to the Rescue.The intriguing role of soluble urokinase receptor in inflammatory diseases.CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS).

P2860

Q26738374-D0A61D1E-FF3A-4FAF-AED8-024ABF3A1DCF Q26744558-9F824CC3-048F-4F39-BD56-F2EEAA81DE83 Q26776389-B0E5B15B-21BE-452A-9F74-5F90680E6E82 Q33634270-499748FA-D262-4610-B16E-05B123F5321A Q33634943-D09D56FC-0592-460A-A9B7-486371AD8ACE Q33783271-E83A0E19-177B-48CF-B7DE-80FDFF398923 Q34231973-E82510CA-A709-4033-8BD8-B60A3BC292ED Q34455143-7BE89ACB-5096-4C5C-82B4-A528B2AA6433 Q35132279-37AD8C42-6509-4874-886F-7809A085B0C9 Q35779133-E7F2935F-2241-4A2E-9D7B-9922D79D86B9 Q36549551-4717C5B3-F7F6-4CD1-8B8C-868162567026 Q37658483-1685A2CE-5E1B-4F2C-B8B8-18EDDED459D5 Q37742644-AC087129-320B-44FF-9078-34CBB9DD99CE Q38164339-E2302141-6CAE-43D7-97C5-72DC30626C5B Q38192853-2AEDA204-CBD5-433F-889E-F4B63823F2AE Q38203501-DF0FF587-F232-4CD6-ADB2-4DC6B57C1BBB Q38270521-D73FC337-8D08-4D6A-8F5B-212E17DB78D3 Q38275115-4C520B30-D8B5-4D5F-9E66-33DFF31BF0C4 Q38359297-38EE5F40-E4AB-40BB-B7FF-1E933EBA7272 Q38718670-C9094FF6-3802-4745-BA39-47A98B9E32FE Q38742004-C99BB9D9-5AA2-4C3E-90A5-0AFA1B142D57 Q38763898-F1E82351-3EED-457B-9233-04D8CA7AF187 Q39331611-0CA6AD20-BDF6-43D4-A8EC-A358CF2F4E65 Q41269163-1D0DF1DD-5FA6-4A63-9CB5-2C392FB1A251 Q41688065-5398FE3A-BC3E-4D3C-B02C-BE23094BE593 Q42696925-3D4C6272-C44D-458A-9202-B851983383DB Q43063370-D3702A97-99E3-4FE7-9047-277466BC0686 Q43195589-0BEDDB4C-40A7-4381-8852-998349BB84CB Q47153937-79DC9656-2139-41C5-A3C5-D9B6CD0A1565 Q47656083-66F34F6C-1557-4004-B8B4-635C47A7FFB3 Q49124480-883636CE-4067-4949-AC51-738A1E92DC94 Q55228805-03F920DD-B95E-4D57-BF09-0647E8D95D19

P2860

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

http://www.wikidata.org/entity/Q33993597

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Urine but not serum soluble ur ...... n kidney transplant candidates

@ast

Urine but not serum soluble ur ...... n kidney transplant candidates

@en

type

label

Urine but not serum soluble ur ...... n kidney transplant candidates

@ast

Urine but not serum soluble ur ...... n kidney transplant candidates

@en

prefLabel

Urine but not serum soluble ur ...... n kidney transplant candidates

@ast

Urine but not serum soluble ur ...... n kidney transplant candidates

@en

P1433

Q33993597-2B849471-806B-4FB9-AF89-70C49D30416F

P1476

Q33993597-389B7509-6479-479C-BBB7-78C8D05CFC96

P2093

Q33993597-07933EDD-4269-48F8-965A-4BB58D2EEE17

Q33993597-0C493ABD-42A3-45E9-ABAA-8CE119E0CAE3

Q33993597-1411EAC3-BA10-4A07-8614-9C7D175DD31E

Q33993597-1A39F1FC-E2C7-4A02-B66C-C6DF151248C2

Q33993597-2E295E55-CEDE-4E81-8705-759A8C37EF18

Q33993597-70AD5AF9-F503-4725-B371-B35FDDFE31CD

Q33993597-74DF8CAF-191C-4346-947A-3B0554E3B6E0

Q33993597-7BA73573-B6E5-42DD-B191-51A92DA4B15E

Q33993597-8770C147-BCBA-4250-AED7-282905E439ED

Q33993597-FDDAD2FD-A055-404C-9129-DFFE1067E9F6

P2860

Q33993597-2077368D-24A9-43DE-A8F6-DEBB2C4ED663

Q33993597-6161ED24-B50E-4358-BF98-929BB6411C15

Q33993597-63F5E883-C274-482E-8635-1D35A23A3316

Q33993597-6447FE49-D908-489F-9D52-6E8AF6D26FA7

Q33993597-80F3AC33-223E-4434-9FF3-33ADC917EF0F

Q33993597-8E1581AC-5DEE-468B-89E5-4A0F7EC7B4CC

Q33993597-A9C1BC5A-8309-47CD-AACD-6EF220CE80AE

Q33993597-B966A2DA-C32F-4A72-8D28-4D4B14826A07

Q33993597-B9C9C8D8-10D2-4688-9855-FCE68F7D3E1D

Q33993597-CE44F836-82E2-4603-8DE4-8265CF0B236C

P304

Q33993597-74B41960-4A26-44D6-9112-5FCA1878BAA5

P31

Q33993597-1A8362BE-77FA-4B11-92D4-F4F3A5852688

P356

Q33993597-B58B68BC-B240-425D-90D1-86B26633A363

P433

Q33993597-A9F0293D-CC3C-441E-99E5-47D496F8232B

P478

Q33993597-2951CB1C-CC0F-4E60-A551-657C5D013BDB

P50

Q33993597-14BE0AB3-4E30-4646-9BE6-F56404239172

P577

Q33993597-5CF0D27B-F961-4ABF-84E9-89ECB61443C3

P698

Q33993597-2E65430C-224E-4914-83E5-B817657DD2C8

P932

Q33993597-D69E96C5-A54E-4C22-A5C5-B0F25799C709

P356

TP.0B013E3182977AB1

P1433

Transplantation

P1476

Urine but not serum soluble ur ...... n kidney transplant candidates

@en

P2093

Andrew D Rule

http://www.w3.org/2001/XMLSchema#string

Carlos R Franco Palacios

http://www.w3.org/2001/XMLSchema#string

Fernando C Fervenza

http://www.w3.org/2001/XMLSchema#string

Fernando G Cosio

http://www.w3.org/2001/XMLSchema#string

Hatem Amer

http://www.w3.org/2001/XMLSchema#string

John C Lieske

http://www.w3.org/2001/XMLSchema#string

Ladan Zand

http://www.w3.org/2001/XMLSchema#string

Mark D Stegall

http://www.w3.org/2001/XMLSchema#string

Nikolay Voskoboev

http://www.w3.org/2001/XMLSchema#string

Vesna D Garovic

http://www.w3.org/2001/XMLSchema#string

P2860

suPAR: the molecular crystal ball

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Kidney transplant candidate evaluation.

Circulating suPAR in two cohorts of primary FSGS.

The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review.

Soluble urokinase receptor and focal segmental glomerulosclerosis.

Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases.

Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection.

Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study.

P304

394-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3182977AB1

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23736353

http://www.w3.org/2001/XMLSchema#string

P932

4119827

http://www.w3.org/2001/XMLSchema#string